Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Nucl Med Biol. 2013 Feb 27;40(4):451–457. doi: 10.1016/j.nucmedbio.2013.01.007

Table 2.

Human dosimetry (mGy/MBq) comparison for radionuclide(s) 111In- and 89Zr- labeled panitumumab.

111In-pan 89Zr-pan

Target Organ mGy/MBq mGy/MBq
Adrenals 0.182 0.599
Brain 0.048 0.212
Breasts 0.112 0.391
Gallbladder 0.164 0.522
LLI 0.170 0.711
Small 0.116 0.480
Stomach 0.127 0.460
ULI 0.138 0.549
Heart 0.854 2.900
Kidneys 0.149 0.541
Liver 0.297 0.723
Lungs 0.533 0.953
Muscle 0.109 0.402
Ovaries 0.115 0.476
Pancreas 0.174 0.578
Red Marrow 0.175 0.816
Osteogenic 0.214 0.677
Skin 0.056 0.243
Spleen 0.213 0.725
Testes 0.067 0.293
Thymus 0.223 0.737
Thyroid 0.093 0.353
Urinary Bladder 0.096 0.418
Uterus 0.105 0.435
Total 0.123 0.434
Effective Dose Equivalent (mSv/MBq) 0.246 0.769
Effective Dose (mSv/MBq) 0.183 0.578